secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001193125-23-079227
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

biote Corp. restating 2022 Q2/Q3 results; earnout liability error, EPS revision
-------------------------------------------------------------------------------

- Audit committee determined Q2 and Q3 2022 unaudited financials should no longer be relied upon due to earnout valuation error.
- Error overstated earnout liability and gain/loss from change in fair value; restatement to reduce both.
- Changes in fair value of warrant and earnout liabilities will be attributed to operating subsidiary Holdings, not parent.
- Restatement will reduce basic and diluted earnings per share; no impact on revenue, operating income, or cash flows.
- Company does not believe the error stems from a material weakness in internal controls.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312523079227/0001193125-23-079227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312523079227/d475596d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-079227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer